menu search

RPHM / Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences

Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company's management team will participate at the following conferences in September, as detailed below: Read More
Posted: Sep 6 2022, 08:35
Author Name: GlobeNewsWire
Views: 042519

RPHM News  

Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop

By Seeking Alpha
October 29, 2023

Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop

Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavodelpar or REN001. Mavodelpar has shown promising more_horizontal

Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences

By GlobeNewsWire
September 6, 2022

Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences

IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the more_horizontal


Search within

Pages Search Results: